◀ Back to TGFB2
PCNA — TGFB2
Text-mined interactions from Literome
Wolf et al., Kidney Int Suppl 2000
(Diabetic Nephropathies) :
High glucose,
transforming growth factor-beta ( TGF-beta ), angiotensin II, and probably other factors
induce inhibitors of
cyclin dependent kinases (CDK) including p21Cip1 and p27KiP1
Stieger et al., Diabetes Metab Res Rev 2011
(Diabetes Mellitus, Type 1...) :
Common pathway components induced by high glucose and advanced glycation end-products are reactive oxygen species,
cyclin dependent kinases ( p27 ( Kip1 ) ) and
transforming growth factor-beta
Payne et al., Int J Dev Biol 2013
:
Cyclin dependent kinase inhibitors, activated retinoblastoma 1 protein, and increased levels of
transforming growth factor beta 2 collectively influence this cell cycle arrest
Rao et al., J Biol Chem 1995
:
Positive and negative
regulation of D-type
cyclin expression in skeletal myoblasts by basic fibroblast growth factor and
transforming growth factor beta
Quesnel et al., Blood 1998
(Myelodysplastic Syndromes) :
p15(INK4b) gene is an inhibitor of
cyclin dependent kinase (CDK) 4 and CDK6 whose expression is
induced by
transforming growth factor ( TGF ) beta